Reddy K N
J Biol Chem. 1976 Nov 10;251(21):6624-9.
The rate of activation of dog plasminogen by excess streptokinase showed a significant delay as compared to the rate of activation with catalytic amounts of streptokinase. Studies of the reaction at high streptokinase levels with the active center reagent, p-nitrophenyl-p-guanidinobenzoate showed that only a fraction (13%) of the potential active centers were developed in a equimolar mixture of streptokinase and dog plasminogen in 15s and more than 10 min were required for the formation of 1 mol of active sites. In the first 15s, the yield of active sites could not be increased by increasing streptokinase 10-fold over the molar concentration of plasminogen, suggesting that active center development rather than complex formation was the rate-limiting step. The delayed reactivity seen in this system provides an interesting model for the study of conformationally induced active center formation. With catalytic amounts of streptokinase, the activation proceeded rapidly but reached a plateau, indicating the loss of activator activity in the reaction mixture. With successive additions of fresh streptokinase, complete activation was achieved. Polyacrylamide gel electorphoresis showed that a stable streptokinase-plasmin complex formed. However, in contrast to the human plasmin-steptokinase complex, a potent plasminogen activator in which streptokinase is found as a residue of 37,000 daltons, dog plasmin-streptokinase complex contained a residue of 25,700 daltons and the complex was inactive against canine and human plasminogen. The 25,700 fragment along, however, showed considerable activator activity when tested with human and dog plasminogens.
与催化量链激酶激活犬纤溶酶原的速率相比,过量链激酶激活犬纤溶酶原的速率出现了显著延迟。用活性中心试剂对硝基苯基 - 对 - 胍基苯甲酸研究高链激酶水平下的反应表明,在链激酶与犬纤溶酶原的等摩尔混合物中,15秒内仅形成了一小部分(13%)潜在活性中心,形成1摩尔活性位点需要超过10分钟。在最初的15秒内,将链激酶浓度比纤溶酶原摩尔浓度提高10倍并不能增加活性位点的产量,这表明活性中心的形成而非复合物的形成是限速步骤。该系统中观察到的反应延迟为研究构象诱导的活性中心形成提供了一个有趣的模型。使用催化量的链激酶时,激活迅速进行但达到平台期,表明反应混合物中激活剂活性丧失。随着新鲜链激酶的连续添加,实现了完全激活。聚丙烯酰胺凝胶电泳显示形成了稳定的链激酶 - 纤溶酶复合物。然而,与人类纤溶酶 - 链激酶复合物(一种有效的纤溶酶原激活剂,其中链激酶以37,000道尔顿的残基形式存在)不同,犬纤溶酶 - 链激酶复合物含有一个25,700道尔顿的残基,并且该复合物对犬和人类纤溶酶原均无活性。然而,单独的25,700片段在用人类和犬纤溶酶原测试时显示出相当大的激活剂活性。